Life Science

Più recente

281 a 290 di 473
  • Italian investigation into Pfizer - developments in the Xalatan case Accesso limitato

    Articolo

    Ultima consultazione: 25 July 2011 / Inviato: 25 July 2011

    In October 2010, the Italian Competition Authority opened an investigation into Pfizer. This article reviews this development in the context of the Life Sciences industry sector.

  • Counterfeit drugs and increased competition: Qatar to issue new laws Accesso limitato

    Articolo

    Ultima consultazione: 21 July 2011 / Inviato: 21 July 2011

    Qatar`s Supreme Council of Health`s Pharmacy and Drug Control Department has announced in a new draft law to combat the sale of counterfeit drugs in the country.

  • Falling between two stools? Accesso limitato

    Articolo

    Ultima consultazione: 06 July 2011 / Inviato: 06 July 2011

    This article considers the difficulties of applying the SPC regime to medicines comprising combination products.

  • UK patent box: further consultation, further complexity Accesso limitato

    Articolo

    Ultima consultazione: 16 June 2011 / Inviato: 16 June 2011

    The Government`s further consultation on the UK patent box contains some welcome extensions to the scope of the regime offering a 10 per cent rate of tax on profits from patents, but equally indicates that calculating the amount of profits that fall within the regime may be challenging and administratively burdensome.

  • Outsourcing for pharmaceuticals and biotech companies in China: what to bear in mind Accesso limitato

    Articolo

    Ultima consultazione: 31 May 2011 / Inviato: 31 May 2011

    A brief guide to intellectual property issues concerning outsourcing in China.

  • Patent settlement agreement under scrutiny Accesso limitato

    Articolo

    Ultima consultazione: 05 May 2011 / Inviato: 05 May 2011

    The European Commission has opened a formal investigation into an agreement between pharmaceutical companies Cephalon and Teva.

  • Abuse of dominance fine confirmed and damages action underway: the Gaviscon case Accesso limitato

    Articolo

    Ultima consultazione: 04 May 2011 / Inviato: 04 May 2011

    The UK OFT has confirmed the terms of the settlement reached with Reckitt Benckiser to resolve the abuse of dominance case relating to Gaviscon - but a private damages action against the pharma company is already underway.

  • Bioethics in Italy: the right of self determination Accesso limitato

    Articolo

    Ultima consultazione: 13 May 2011 / Inviato: 03 May 2011

    In November 2010, the Italian Supreme Court examined again the controversial matter of doctors’ liability for failing to provide adequate information to patients on available treatments.

  • Middle East and North Africa: questions in times of uncertainty

    Articolo

    Ultima consultazione: 13 April 2011 / Inviato: 13 April 2011

    Recent months have seen significant upheaval in the Middle East and North Africa region, giving rise to certain legal risk management questions.

  • European patent litigation: the Gordian knot Accesso limitato

    Articolo

    Ultima consultazione: 31 March 2011 / Inviato: 31 March 2011

    The European patent system is complicated, expensive and illogical. This article aims to unpick some of the mystery for those seeking to litigate within it. This article forms part of our Unified Patent Court Toolkit.

281 a 290 di 473